Leukaemia UK is very proud of our 40-year partnership with King's College Hospital in London. Together, we are working hard to make blood cancer care kinder and more effective.

Our achievements include:

Isobel Mitchell DNA Laboratory, in the Rayne Institute: Opened in 1988 with a £450,000 grant from Leukaemia UK, this was an important step in establishing the Haematology Department at King’s College Hospital as a world class centre of research. The laboratory was refurbished in 2005 and continues to provide support for research into all haematological diseases.

Cell Therapy Unit: Part of the Centre of Experimental Medicine, this unit was established with a £150, 000 contribution from Leukaemia UK. Building on the hospital's reputation as a leading centre of bone marrow transplants, this unit is researching kinder ways of fighting leukaemia,  such as altering cells from peripheral blood and bone marrow which can fight diseased cells in leukaemia while leaving healthy cells untouched.  

Derek Mitchell Unit: Named after Leukaemia UK's founder, Derek Mitchell, this part of a purpose-built chemotherapy and bone marrow transplant unit that carries out about 120 transplants per year. It has 14 single isolation rooms, all en suite, providing a safe environment for the care of patients receiving high dose chemotherapy or bone marrow transplants for blood cancers such as leukaemia, lymphoma or myeloma.

Apheresis Unit: This dedicated nurse-led unit is an integral part of the Department of Haematology and has seen a steady increase in the number and range of procedures performed to help people with blood cancer. In 2008, Leukaemia UK provided a grant of £25,700 for a new machine, and in 2012 another £45,500 for a photopheresis machine to help combat graft versus host disease.

ELF and LIBRA ward: We are so proud that King's chose to name its latest haematology ward after us in recognition of almost 40 years of funding and support to improve the care of leukaemia patients. Opened in 2015, the ward provides the hospital with additional bed space for patients with leukaemia and non leukaemic blood disorders such as sickle cell. Leukaemia UK was originally named the Elimination of Leukaemia Fund, known as ELF.

Leukaemia UK Ambulatory Care Unit: People undergoing treatment for a range of blood cancers are benefiting from this new outpatient unit, which opened in 2016. It provides facilities and care for people to undergo stem cell transplants on a day-release basis.  They can then be cared for by their families if they live nearby, knowing that specialist help is on hand should they need it.  This approach enables people with blood cancer to reduce their hospital stays and access help only when they need it.   It is also possible to visit this unit daily for treatments such as chemotherapy, prior to and following a bone marrow or stem cell transplant. Leukaemia UK paid for this facility to be built and for a specialist staff nurse position to manage the unit.